Autism Spectrum Disorder Trial, Recruiting (NCT06698068)

Autism Spectrum Disorder Trial, Recruiting NCT06698068 Sponsor: Hopital La Musse Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06698068 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children who are between 8 and 12 years old.
Children who have been diagnosed with autism spectrum disorder (ASD) by a doctor.
Children who are physically able to take part in horse-assisted therapy sessions.
Children who are able to understand and follow instructions during horse-assisted therapy sessions.
Children who are enrolled in the social security system.

Who may not be able to join:

Children who have ASD along with one or more of the following additional diagnoses: ADHD (attention and hyperactivity difficulties), ODD (persistent defiant or oppositional behaviour), intellectual developmental disorder, or a language and communication disorder that affects understanding.
Children who are already receiving horse-assisted therapy as part of another programme.
Children who have other serious medical conditions that could make it difficult to take part in the sessions.
Children who have an allergy to horses.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33(0)232293047

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06698068

Sponsor: Hopital La Musse

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +33(0)232293047

More information: https://clinicaltrials.gov/study/NCT06698068

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children who are between 8 and 12 years old.
Children who have been diagnosed with autism spectrum disorder (ASD) by a doctor.
Children who are physically able to take part in horse-assisted therapy sessions.
Children who are able to understand and follow instructions during horse-assisted therapy sessions.
Children who are enrolled in the social security system.

Who may not be able to join:

Children who have ASD along with one or more of the following additional diagnoses: ADHD (attention and hyperactivity difficulties), ODD (persistent defiant or oppositional behaviour), intellectual developmental disorder, or a language and communication disorder that affects understanding.
Children who are already receiving horse-assisted therapy as part of another programme.
Children who have other serious medical conditions that could make it difficult to take part in the sessions.
Children who have an allergy to horses.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hopital La Musse

Registry

ClinicalTrials.gov

Start date

12 September 2024

Est. completion

12 September 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Score obtained from the Pediatric Quality of Life Inventory™ (PedsQl™) 4.0 - Quality of life child and parent

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov